Banco Santander, S.A. Press Releases

SAN 
$8.77
*  
0.04
0.45%
Get SAN Alerts
*Delayed - data as of Oct. 22, 2014 10:47 ET  -  Find a broker to begin trading SAN now
Exchange: NYSE
Industry: Finance
Community Rating:
View:    SAN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Santander Holdings USA Declares Quarterly Dividend On Preferred Stock
10/22/2014 10:54:00 AM - PR Newswire


Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
10/20/2014 10:35:00 AM - Business Wire


US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine
10/20/2014 8:00:00 AM - Business Wire


Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis
10/20/2014 7:00:00 AM - PR Newswire


Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy
10/16/2014 8:00:00 AM - GlobeNewswire


New Survey Finds Differences In Attitudes About Diabetes Based On Age
10/15/2014 8:00:00 AM - PR Newswire


Santander Sponsors Special Exhibition of Spanish Master Francisco Goya at Museum of Fine Arts, Boston
10/2/2014 12:02:00 PM - PR Newswire


Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards
10/1/2014 8:00:00 AM - Business Wire


Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps
9/30/2014 1:00:00 AM - PR Newswire


Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness
9/24/2014 8:00:00 AM - Business Wire


Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease
9/17/2014 8:34:00 AM - PR Newswire


Santander Renews And Expands Its Commitment To Boston University
9/11/2014 3:11:00 PM - PR Newswire


At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
9/11/2014 1:00:00 AM - Business Wire


Grupo Financiero Santander Mexico Regrets to Announce that its Parent Company, Banco Santander, S.A. Chairman Emilio Botin has Passed Away
9/10/2014 10:33:00 AM - PR Newswire


Genzyme Announces Launch of “Expression of Hope III” Program to Build Awareness of Lysosomal Storage Disorders Through Works of Art
9/10/2014 8:00:00 AM - Business Wire


Google Executes $145 Million Investment In SunEdison And TerraForm Power's Largest Solar Plant In North America
9/10/2014 7:00:00 AM - PR Newswire


FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease
9/8/2014 2:14:00 PM - PR Newswire


Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS
9/8/2014 8:00:00 AM - Business Wire


San Antonio Ventures Inc. Announces Closing of Reverse Take-Over With R2 Energy Ltd.
9/4/2014 12:53:00 PM - Market Wire


Sanofi Diabetes is on a Mission to Support Children, Parents and Carers of Children with Type 1 Diabetes through Gaming
9/2/2014 7:01:00 PM - Business Wire


Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients
9/2/2014 8:30:00 AM - PR Newswire


Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
8/31/2014 3:00:00 AM - PR Newswire


Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
8/31/2014 3:00:00 AM - PR Newswire


Santander And New England Revolution Encourage Parents To Share Their Child's Academic Achievements For Chance To Play With The Pros
8/28/2014 12:57:00 PM - PR Newswire


Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
8/25/2014 1:00:00 AM - PR Newswire